The crystal formations were found during an investigation in a different lot than the two sent to customers and later recalled. Crystallization in drug solutions can disrupt the distribution of the active pharmaceutical ingredient, raising the risk of over- or under-dosing.
The drug is indicated for the prophylaxis of organ rejection in kidney, liver and heart allogeneic transplants, according to the agency. Sandimmune is also used for chronic rejection in patients who have received other immunosuppressive agents.
No adverse events related to the recall have been reported.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.